Notwithstanding, we are currently investigating whether SAMHD1 expression affects the rate of negative minimal residual disease (MRD) following ara-C-based induction courses as MRD significantly correlates with AML relapse. The gene discussed is SAMHD1; the disease is acute myeloid leukemia.